Showing results (41-50 of 129) with videos related to

Sort By:
Pageof 13
International Journal of Molecular Sciences|October 13, 2021
Multimodal Strategy in Localized Merkel Cell Carcinoma: Where Are We and Where Are We Heading?Gianluca Ricco, Elisa Andrini, Giambattista Siepe, et al.
Diagnostics (Basel, Switzerland)|June 2, 2021
A [68Ga]Ga-DOTANOC PET/CT Radiomic Model for Non-Invasive Prediction of Tumour Grade in Pancreatic Neuroendocrine TumoursAlessandro Bevilacqua, Diletta Calabrò, Silvia Malavasi, et al.
International Journal of Molecular Sciences|March 7, 2018
The Role of mTOR in Neuroendocrine Tumors: Future Cornerstone of a Winning Strategy?Giuseppe Lamberti, Nicole Brighi, Ilaria Maggio, et al.
Cancers|February 25, 2022
Radiolabeled Somatostatin Analogues for Diagnosis and Treatment of Neuroendocrine TumorsValentina Ambrosini, Lucia Zanoni, Angelina Filice, et al.
Cancer Biotherapy & Radiopharmaceuticals|May 5, 2009
Small animal PET in oncology: the road from bench to bedsideValentina Ambrosini, Carmelo Quarta, Cristina Nanni, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 14, 2017
The Impact of Somatostatin Receptor-Directed PET/CT on the Management of Patients with Neuroendocrine Tumor: A Systematic Review and Meta-AnalysisMartin Barrio, Johannes Czernin, Stefano Fanti, et al.
Annals of Nuclear Medicine|July 5, 2008
Early relapse in a patient with Hodgkin's disease and negative interim FDG-PETStefano Fanti, Paolo Castellucci, Vittorio Stefoni, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|March 1, 2018
Is radical surgery always curative in pancreatic neuroendocrine tumors? A cure model survival analysisClaudio Ricci, Riccardo Casadei, Giovanni Taffurelli, et al.
Insights Into Imaging|February 21, 2012
Imaging with non-FDG PET tracers: outlook for current clinical applicationsEgesta Lopci, Cristina Nanni, Paolo Castellucci, et al.
Pageof 13